Literature DB >> 27414233

Characteristics of Congenital Coronary Artery Fistulas Complicated with Infective Endocarditis: Analysis of 25 Reported Cases.

Salah Am Said1.   

Abstract

Congenital coronary artery fistulas (CAFs) are infrequent congenital coronary artery anomalies. Complications such as left-to-right shunt, congestive heart failure, myocardial infarction, pericardial effusion, aneurysm formation, rupture, hemopericardium, pulmonary hypertension, infective endocarditis (IE), syncope, stroke, and sudden death may occur with a variable low frequency. To describe the clinical characteristics of patients with CAFs complicated by IE. A search was conducted through PubMed using the terms "CAFs" and "IE." Papers with a full description of the fistula characteristics and detailed data regarding bacterial endocarditis were included for evaluation. In the overall group of reviewed subjects (n = 25, 9 females), the mean patient age was 42.5 years (range: 16 and 87). The right coronary artery (RCA) and left coronary artery (LCA) contributed equally to fistula formation. Terminations into the right heart side occurred in 19 (76%) fistulas. The majority of the fistulas (92%) were unilateral. The cultured microorganism was Streptococcus in 14 (56%) and Staphylococcus in 4 (16%) of the reviewed subjects. Echocardiographic single or multiple valvular regurgitation was found in 8 (32%) of the reviewed subjects. Small and large intracardiac vegetations were detected in 18 patients (72%). Antibiotic therapy was initiated in 20 (80%) subjects and 16 fistulas were treated surgically. During surgery, spontaneous closure of the fistula was observed in one patient. Percutaneous therapeutic embolization (PTE) was successfully performed in two subjects. CAFs complicated by IE may affect all age groups with a slight male preponderance. Unilateral fistulas, either arising from the right or left coronary artery, are predominant, draining mainly into the right heart side. It is emphasized that antibiotic prophylaxis is strongly advised for pediatric and adult patients with congenital CAFs.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Congenital Anomaly; Congenital Coronary Artery Fistulas; Fistula Characteristics; Infective Endocarditis; Surgical Closure; Valvular Heart Disease

Mesh:

Substances:

Year:  2016        PMID: 27414233     DOI: 10.1111/chd.12392

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  6 in total

1.  The characteristics of coronary-pulmonary artery fistulas and the effectivity of trans-catheter closure: a single center experience.

Authors:  Xin Liu; Lei Zhang; Zhiyong Qi; Mengkang Fan; Junbo Ge
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

2.  The curious case of coronary cameral fistula with infective endocarditis: A rare harbinger of a common clinical entity.

Authors:  Deepi P Agrawal; Abhishek S Joshi; Sunay Nm
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-04-26       Impact factor: 0.332

Review 3.  Fistula between the right coronary artery and coronary sinus: a case report and literature review.

Authors:  Miao Yuan; Wen Juan Bai; Chun Mei Li; Li Rao
Journal:  Anatol J Cardiol       Date:  2017-07       Impact factor: 1.596

4.  Endocarditis and coronary artery fistula: a case report.

Authors:  Thomas Green; Jenifer Crilley
Journal:  Eur Heart J Case Rep       Date:  2018-02-28

Review 5.  Congenital coronary artery-to-pulmonary fistula with giant aneurysmal dilatation and thrombus formation: a case report and review of literature.

Authors:  Xuanqi An; Shaoxian Guo; Huawei Dong; Yida Tang; Lin Li; Xuejing Duan; Shaodong Ye
Journal:  BMC Cardiovasc Disord       Date:  2021-06-04       Impact factor: 2.298

6.  Surgical repair of a right coronary aneurysm with a coronary artery fistula to the right atrium.

Authors:  Shigeki Yokoyama; Kanetsugu Nagao; Akihiko Higashida; Masaya Aoki; Shigeyuki Yamashita; Akio Yamashita; Toshio Doi; Kazuaki Fukahara; Naoki Yoshimura
Journal:  J Surg Case Rep       Date:  2021-07-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.